₦15,500.00
Buy Now CompareRelipoietin Erythropoietin Injection 4000IU is a recombinant human erythropoietin used to stimulate red blood cell production. This injectable medication is crucial in managing anemia associated with chronic kidney disease, chemotherapy, and other conditions. The 4000IU strength allows for precise dosing based on individual patient needs.
Erythropoietin stimulates erythropoiesis by interacting with progenitor stem cells in the bone marrow. This interaction promotes the proliferation and differentiation of red blood cells, increasing hemoglobin levels and improving oxygen-carrying capacity of the blood.
Dosing is individualized based on the patient’s condition, weight, and hemoglobin levels. Typically, treatment starts with lower doses and is adjusted based on response. Always follow the prescribing physician’s instructions for dosage and administration.
Common side effects may include injection site reactions, headache, joint pain, and flu-like symptoms. Serious side effects, though rare, can include increased blood pressure, blood clots, and seizures. Patients should report any unusual symptoms to their healthcare provider immediately.
Relipoietin should be used with caution in patients with uncontrolled hypertension, history of seizures, or thrombotic events. Regular monitoring of hemoglobin levels and blood pressure is essential during treatment. It’s not recommended for use in patients with certain types of cancer.
Relipoietin is a prescription medication that should only be used under medical supervision. Regular blood tests are necessary to monitor hemoglobin levels and adjust dosage. Patients should be educated about the signs and symptoms of thrombotic events. Store the medication as directed, usually refrigerated and protected from light. Do not shake the vial before use. Use each vial only once and discard any unused portion. Report any symptoms of pure red cell aplasia, such as severe anemia with low reticulocyte count, to your healthcare provider immediately.
Condition | Dosage |
---|---|
Chronic Kidney Disease (CKD) | Adults: 50-100 units/kg, 3 times weekly, adjusted based on response and hemoglobin levels |
Pediatrics: 50 units/kg, 3 times weekly, adjusted based on response and hemoglobin levels | |
Cancer Patients on Chemotherapy | Adults: 150 units/kg, 3 times weekly, or 40,000 units weekly, adjusted based on response and hemoglobin levels |
Surgery Patients | Adults: 300 units/kg daily for 10 days before surgery, on the day of surgery, and for 4 days after surgery |
Alternative: 600 units/kg weekly, starting 3 weeks before surgery, plus a dose on the day of surgery |
Reviews
There are no reviews yet.